Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism - 16/02/13
Corresponding author. Tel.: +1-608-263-1387; fax: +1-608-263-7652.Abstract |
Background |
In hyperparathyroidism, dual-phase technetium-99m sestamibi scintigraphy is important for parathyroid adenoma localization. We hypothesized that reviewing early-phase scans can increase localization in patients with primary hyperparathyroidism (PHPT).
Methods |
We reviewed our prospectively maintained database for patients with sestamibi scans before parathyroidectomy for PHPT from 2001 to 2011. Early-phase scans were read and compared with the location of the gland(s) removed at operation.
Results |
Of 902 patients identified, radiologists read 693 scans as positive. Of 209 negative scans, 141 (67%) were positive in the early phase; 135 (96%) correctly identified the side of the adenoma. Using radiologist reads, 35% of patients with negative scans and 41% of patients with falsely localized glands required bilateral exploration compared with 5% of patients with correctly localized glands.
Conclusions |
A review of early scans in patients with negative imaging increases accurate adenoma localization and allows for minimally invasive operations in more patients.
Le texte complet de cet article est disponible en PDF.Keywords : Early-phase sestamibi, Minimally invasive parathyroidectomy, Primary hyperparathyroidism, Technetium-99m sestamibi
Plan
| The authors declare no conflicts of interest. |
Vol 205 - N° 3
P. 269-273 - mars 2013 Retour au numéro
Article précédent
- Extraction site location and incisional hernias after laparoscopic colorectal surgery: should we be avoiding the midline?
- Hoda Samia, Justin Lawrence, Tamar Nobel, Sharon Stein, Bradley J. Champagne, Conor P. Delaney
- Anterior abdominal stab injury: a comparison of self-inflicted and intentional third-party stabbings
- Aman Banerjee, Hannah Y. Zhou, Katherine B. Kelly, Bianca D. Downs, John J. Como, Jeffrey A. Claridge
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?